Niclosamide formulations for treating disease

The invention relates to a method of treating a viral infection caused by or associated with SARS-CoV-2 in a subject, the method comprising administering to the subject by inhalation intraorally and/or intranasally a therapeutically effective amount of a formulation comprising niclosamide, or a phar...

Full description

Saved in:
Bibliographic Details
Main Authors Sommer, Morten Otto Alexander, Andres, Philippe, Ditzinger, Günter, Knopp, Matthias Manne, Toft-Kehler, Anne Katrine, Jellingsoe, Mads, Toft-Kehler, Rasmus
Format Patent
LanguageEnglish
Published 29.06.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a method of treating a viral infection caused by or associated with SARS-CoV-2 in a subject, the method comprising administering to the subject by inhalation intraorally and/or intranasally a therapeutically effective amount of a formulation comprising niclosamide, or a pharmaceutically acceptable salt thereof, and a cyclodextrin.
Bibliography:Application Number: US202017097898